Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,671.60
Bid: 1,659.20
Ask: 1,660.20
Change: 13.80 (0.83%)
Spread: 1.00 (0.06%)
Open: 1,649.20
High: 1,678.20
Low: 1,646.40
Yest. Close: 1,657.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

GSK's ViiV Trials Monthly HIV Treatment In US Clinics

(Alliance News) - GlaxoSmithKline PLC on Monday said ViiV Healthcare has commenced a trial to identify and evaluate approaches to implementing a once-monthly, injectable treatment for HIV into is

8 Jul 19 13:53

Glaxo Notes European Commission Authorisation For HIV Drug Dovato

(Alliance News) - GlaxoSmithKline PLC on Wednesday announced the European Commission has given marketing authorisation to HIV-1 drug Dovato.Dovato, a two-drug regimen of dolutegravir and by

3 Jul 19 09:41

GlaxoSmithKline's Zejula application accepted by US Food and drug administration

(Sharecast News) - GlaxoSmithKline (GSK) confirmed on Monday Tesaro, its oncology-focused business, submitted a supplemental new drug application to the US Food & Drug Administration for its Zejula cancer treatment.

24 Jun 19 13:18

US Food & Drug Administration Accepts GSK's Application For Zejula

(Alliance News) - GlaxoSmithKline PLC on Monday said Tesaro, its oncology-focused business, submitted a supplemental new drug application to the US Food & Drug Administration for drugmaker the

24 Jun 19 12:25

Monday broker round-up

(Sharecast News) - Hammerson: Peel Hunt upgrades to add with a target price of 350p.

17 Jun 19 12:21

GSK to update on potential cancer treatment at European congress

(Sharecast News) - GlaxoSmithKline is to present studies on a potential breakthrough cancer treatment at a major conference, the drugs giant confirmed on Wednesday.

12 Jun 19 12:34

LONDON MARKET PRE-OPEN: Smiths Finds Medical CEO; Ferrexpo Improves

LONDON (Alliance News) - Stock prices in London are set to open higher Friday after a disappointing finish Thursday as the European Central Bank failed to boost sentiment.In London, FTSE Smiths a

7 Jun 19 07:36

US approves self administration for GlaxoSmithKline asthma drug

(Sharecast News) - GlaxoSmithKline said on Friday that US regulators had approved two new methods for self-administering its Nucala asthma treatment.

7 Jun 19 07:15

May And Trump To Co-Host Meeting With UK And US Business Leaders

LONDON (Alliance News) - Prime Minister Theresa May and US President Donald Trump will co-host a meeting of British and American business leaders in a bid to boost trade.The prime minister

4 Jun 19 07:28

Fitch Cuts Glaxo Default Rating To A- From A After Acquisitions

LONDON (Alliance News) - Fitch Ratings on Tuesday downgraded GlaxoSmithKline PLC's long-term issuer default rating to A- from A as it expects Glaxo's leverage to remain high after recent a

29 May 19 10:37

GlaxoSmithKline's Shingrix Shingles Vaccine Gets Chinese Approval

LONDON (Alliance News) - GlaxoSmithKline PLC on Thursday said its Shingrix vaccine has been approved in China for the prevention of shingles in adults over 50 years old.Shingles is caused a

23 May 19 17:14

Thermo Fisher To Buy Irish Glaxo Manufacturing Site For EUR90 Million

LONDON (Alliance News) - Thermo Fisher Scientific Inc on Thursday announced a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline PLC for in

16 May 19 11:26

WINNERS & LOSERS SUMMARY: Domino's Pizza Warns Of International Loss

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 1.8%. The telecommunications firm said it

7 May 19 10:44

Glaxo Says Phase Three Study Of Trelegy Ellipta Meets Primary Endpoint

LONDON (Alliance News) - GlaxoSmithKline PLC and its partner Innoviva Inc on Thursday said the phase three Captain study of once-daily single inhaler triple therapy Trelegy Ellipta met its primary

2 May 19 17:24

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 2 MayOld MutualMpac GroupHowden Joinery GroupReachKAZ 3 6

1 May 19 16:20

Login to your account

Don't have an account? Click here to register.